We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Next Generation SCS Personalizes Pain Relief

By HospiMedica International staff writers
Posted on 24 Jun 2021
Print article
Image: The Vanta SCS implantable neurostimulator (Photo courtesy of Medtronic)
Image: The Vanta SCS implantable neurostimulator (Photo courtesy of Medtronic)
A new high performance spinal cord stimulation (SCS) implantable neurostimulator (INS) offers up to 11 years of battery life.

The Medtronic (Dublin, Ireland) Vanta INS offers personalized pain relief that adapts to the patient's movement or body position using a built-in accelerometer that delivers the right therapy dose to the right location, even as the pain target shifts according to body position. Called AdaptiveStim, the technology can also automatically adjust stimulation to provide each patient's optimal dose. In addition, Snapshot reporting (Medtronic's proprietary data insights solution), offers clinicians objective reporting of patient activity levels to empower objective health conversations.

Vanta INS uses SureScan magnetic resonance imaging (MRI) technology for diagnostic imaging and simple eligibility determination, which allows MRI scans to be performed anywhere on the body. In addition, for first time users, a mobile application and web portal (CareGuidePro) serves as a virtual guide for patients throughout their Medtronic SCS therapy journey. A unique feature of the system is the recharge-free battery, which offers nearly twice the device life than competitive primary cell devices.

“We are committed to delivering innovative solutions that meet the needs of every patient,” said Charlie Covert, vice president and general manager of Pain Therapies at Medtronic. “For those who prefer or require a recharge-free device, I believe the Vanta neurostimulator offers the best hardware and features available today. We are pleased to offer this solution, which is now part of the strongest and broadest overall portfolio in this market.”

“Not every patient with chronic, intractable pain is an ideal candidate for a rechargeable device, so the Vanta INS represents a welcome addition to my portfolio of available treatment options,” commented interventional pain management physician Krishnan Chakravarthy, MD, PhD. “The extended battery life, broad MRI compatibility, and personalized relief through AdaptiveStim technology allow for a more hassle-free experience and greater freedom for my patients as we manage their chronic pain.”

SCS generates electrical pulses that mask or interrupt pain signals as they travel to the brain, reducing pain sensation. Traditionally, SCS uses equally spaced electrical pulses to replace pain with a tingling sensation similar to paresthesia. SCS is used mostly in the treatment of failed back surgery syndrome, complex regional pain syndrome, and refractory pain due to ischemia.

Related Links:
Medtronic

Gold Supplier
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
New
Surgical Light
HyLED 600 Series
New
Analgesic Gas Delivery System
O-Two Equinox Advantage
New
Endoscopy Display
EndoVue Plus 24”

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Surgical Techniques

view channel
Image: Gut microbiota helps healing in colorectal cancer surgery (Photo courtesy of CRCHUM)

Modifying Intestinal Flora Before Surgery Reduces Postoperative Complications in Colorectal Cancer Patients

Up to 30% of all patients undergoing colorectal surgery suffer from serious complications due to poor healing of their intestinal barrier. Anastomotic complications cause inflammation, serious infection... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.